Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 2
2019 5
2020 3
2021 3
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.
Terslev L, Ostergaard M, Georgiadis S, Brahe CH, Ellegaard K, Dohn UM, Fana V, Møller T, Juul L, Huynh TK, Krabbe S, Ornbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, Hetland ML. Terslev L, et al. Among authors: brahe ch. RMD Open. 2022 Dec;8(2):e002796. doi: 10.1136/rmdopen-2022-002796. RMD Open. 2022. PMID: 36549857 Free PMC article.
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful tapering.
Wetterslev M, Georgiadis S, Sørensen IJ, Pedersen SJ, Christiansen SN, Hetland ML, Brahe CH, Bakkegaard M, Duer A, Boesen M, Gosvig KK, Møller JM, Krogh NS, Jensen B, Madsen OR, Christensen J, Hansen A, Nørregaard J, Røgind H, Østergaard M. Wetterslev M, et al. Among authors: brahe ch. Rheumatology (Oxford). 2022 May 30;61(6):2398-2412. doi: 10.1093/rheumatology/keab755. Rheumatology (Oxford). 2022. PMID: 34636846
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
Michelsen B, Georgiadis S, Di Giuseppe D, Loft AG, Nissen MJ, Iannone F, Pombo-Suarez M, Mann H, Rotar Z, Eklund KK, Kvien TK, Santos MJ, Gudbjornsson B, Codreanu C, Yilmaz S, Wallman JK, Brahe CH, Möller B, Favalli EG, Sánchez-Piedra C, Nekvindova L, Tomsic M, Trokovic N, Kristianslund EK, Santos H, Löve TJ, Ionescu R, Pehlivan Y, Jones GT, van der Horst-Bruinsma I, Ørnbjerg LM, Østergaard M, Hetland ML. Michelsen B, et al. Among authors: brahe ch. Arthritis Care Res (Hoboken). 2022 Jul;74(7):1205-1218. doi: 10.1002/acr.24560. Epub 2022 Apr 29. Arthritis Care Res (Hoboken). 2022. PMID: 33460531 Free article.
Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
Raft MB, Hetland ML, Brahe CH, Hørslev-Petersen K, Midtbøll Ørnbjerg L, Junker P, Biln N, Stengaard-Pedersen K, Østergaard M. Raft MB, et al. Among authors: brahe ch. Scand J Rheumatol. 2022 Jul 14:1-11. doi: 10.1080/03009742.2022.2087900. Online ahead of print. Scand J Rheumatol. 2022. PMID: 35833274
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Terslev L, Brahe CH, Hetland ML, Georgiadis S, Ellegaard K, Juul L, Huynh T, Døhn UM, Fana V, Møller T, Krabbe S, Ørnbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, Østergaard M. Terslev L, et al. Among authors: brahe ch. Rheumatology (Oxford). 2021 Dec 1;60(12):5549-5559. doi: 10.1093/rheumatology/keab276. Rheumatology (Oxford). 2021. PMID: 33748831
Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies.
Curtis JR, Weinblatt ME, Shadick NA, Brahe CH, Østergaard M, Hetland ML, Saevarsdottir S, Horton M, Mabey B, Flake DD 2nd, Ben-Shachar R, Sasso EH, Huizinga TW. Curtis JR, et al. Among authors: brahe ch. Arthritis Res Ther. 2021 Jan 4;23(1):1. doi: 10.1186/s13075-020-02389-4. Arthritis Res Ther. 2021. PMID: 33397438 Free PMC article.
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
Terslev L, Brahe CH, Østergaard M, Fana V, Ammitzbøll-Danielsen M, Møller T, Krabbe S, Hetland ML, Døhn UM. Terslev L, et al. Among authors: brahe ch. Arthritis Res Ther. 2021 Feb 1;23(1):48. doi: 10.1186/s13075-021-02426-w. Arthritis Res Ther. 2021. PMID: 33522948 Free PMC article.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML. Brahe CH, et al. Rheumatology (Oxford). 2020 Jul 1;59(7):1640-1650. doi: 10.1093/rheumatology/kez427. Rheumatology (Oxford). 2020. PMID: 31665497
Association between MRI findings and patient-reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse.
Glinatsi D, Brahe CH, Hetland ML, Ørnbjerg L, Krabbe S, Baker JF, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Terslev L, Huynh TK, Manilo N, Jensen DV, Møller JM, Krogh NS, Østergaard M. Glinatsi D, et al. Among authors: brahe ch. Int J Rheum Dis. 2020 Apr;23(4):488-498. doi: 10.1111/1756-185X.13790. Epub 2020 Jan 28. Int J Rheum Dis. 2020. PMID: 31994328
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictors.
Brahe CH, Krabbe S, Østergaard M, Ørnbjerg L, Glinatsi D, Røgind H, Jensen HS, Hansen A, Nørregaard J, Jacobsen S, Terslev L, Huynh TK, Jensen DV, Manilo N, Asmussen K, Brown Frandsen P, Boesen M, Rastiemadabadi Z, Morsel Carlsen L, Møller JM, Krogh NS, Hetland ML. Brahe CH, et al. Rheumatology (Oxford). 2019 Jan 1;58(1):110-119. doi: 10.1093/rheumatology/key244. Rheumatology (Oxford). 2019. PMID: 30169706
18 results